Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

vTv Therapeutics (VTVT) Net Margin (2016 - 2024)

vTv Therapeutics (VTVT) has disclosed Net Margin for 10 consecutive years, with 21376.47% as the latest value for Q4 2024.

  • Quarterly Net Margin changed N/A to 21376.47% in Q4 2024 from the year-ago period, while the trailing twelve-month figure was 138058.82% through Sep 2025, down 13622822.0% year-over-year, with the annual reading at 1815.34% for FY2024, N/A changed from the prior year.
  • Net Margin hit 21376.47% in Q4 2024 for vTv Therapeutics, down from 486.5% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 25.11% in Q4 2020 to a low of 89562.5% in Q1 2020.
  • Historically, Net Margin has averaged 26450.67% across 4 years, with a median of 14066.01% in 2021.
  • Biggest YoY gain for Net Margin was 9833940bps in 2020; the steepest drop was -8913014bps in 2020.
  • Year by year, Net Margin stood at 25.11% in 2020, then tumbled by -312064bps to 78344.44% in 2021, then soared by 33bps to 52722.22% in 2022, then skyrocketed by 59bps to 21376.47% in 2024.
  • Business Quant data shows Net Margin for VTVT at 21376.47% in Q4 2024, 486.5% in Q1 2024, and 52722.22% in Q4 2022.